Picture of Cosmo Bio logo

3386 — Cosmo Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMicro CapContrarian

Table: Cosmo Bio -2019 group results

Mar 25 (Reuters)- 
          Cosmo Bio Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2019    Dec 31, 2018   Dec 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           7.59            7.26           7.75          3.90    
               (+4.5 pct)      (+2.7 pct)     (+2.1 pct)    (+2.8 pct) 
  Operating      405 mln         328 mln        430 mln      250 mln   
               (+23.5 pct)     (+70.1 pct)    (+6.0 pct)    (+3.7 pct) 
  Recurring      470 mln         403 mln        490 mln      290 mln   
               (+16.5 pct)     (+1.6 pct)     (+4.1 pct)    (+7.5 pct) 
  Net
  Net            237 mln         260 mln        310 mln      180 mln   
               (-8.6 pct)      (+9.4 pct)     (+30.3 pct)   (+0.3 pct) 
  EPS           40.14 yen       43.93 yen      52.29 yen    30.36 yen  
  Ann Div       14.00 yen       14.00 yen      18.00 yen               
  -Q2 Div       6.00 yen        6.00 yen       8.00 yen                
  -Q4 Div       8.00 yen        8.00 yen       10.00 yen               
  
  NOTE - Cosmo Bio Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T

Recent news on Cosmo Bio

See all news